Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Study of the pharmacokinetics of eriodictyol-6-C-β-d-glucoside, a flavonoid of rooibos (Aspalathus linearis) extract, after its oral administration in mice.

Yuyama K, Nakamura Y, Tateyama R, Arakaki R, Tsutsui T, Ishimaru N.

J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 15;1137:121881. doi: 10.1016/j.jchromb.2019.121881. Epub 2019 Nov 25.

PMID:
31881511
2.

Achaete-Scute Homologue 2-Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome.

Otsuka K, Yamada A, Saito M, Ushio A, Sato M, Kisoda S, Shao W, Tsunematsu T, Kudo Y, Arakaki R, Ishimaru N.

Am J Pathol. 2019 Dec;189(12):2414-2427. doi: 10.1016/j.ajpath.2019.08.008. Epub 2019 Sep 17.

PMID:
31539517
3.

Novel effects of rooibos extract on tear and saliva secretion mediated by the muscarinic acetylcholine receptor 3 in mice.

Arakaki R, Ushio A, Kisoda S, Sato M, Nakamura Y, Yuyama K, Tateyama R, Morishita S, Monoi N, Kudo Y, Ishimaru N.

J Oral Biosci. 2019 Sep;61(3):179-182. doi: 10.1016/j.job.2019.06.001. Epub 2019 Aug 7.

PMID:
31400544
4.

IL-10 and CXCL2 in trigeminal ganglia in neuropathic pain.

Iwasa T, Afroz S, Inoue M, Arakaki R, Oshima M, Raju R, Waskitho A, Inoue M, Baba O, Matsuka Y.

Neurosci Lett. 2019 Jun 11;703:132-138. doi: 10.1016/j.neulet.2019.03.031. Epub 2019 Mar 20.

PMID:
30904573
5.

CGRP Induces Differential Regulation of Cytokines from Satellite Glial Cells in Trigeminal Ganglia and Orofacial Nociception.

Afroz S, Arakaki R, Iwasa T, Oshima M, Hosoki M, Inoue M, Baba O, Okayama Y, Matsuka Y.

Int J Mol Sci. 2019 Feb 7;20(3). pii: E711. doi: 10.3390/ijms20030711.

6.

CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.

Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y, Aota K, Azuma M, Ishimaru N.

Front Immunol. 2018 Nov 8;9:2594. doi: 10.3389/fimmu.2018.02594. eCollection 2018.

7.

Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multi-wall carbon nanotubes.

Otsuka K, Yamada K, Taquahashi Y, Arakaki R, Ushio A, Saito M, Yamada A, Tsunematsu T, Kudo Y, Kanno J, Ishimaru N.

PLoS One. 2018 Oct 29;13(10):e0205702. doi: 10.1371/journal.pone.0205702. eCollection 2018.

8.

Preventive effects of mouthguard use while sleeping on recurrent aphthous stomatitis: Preliminary interventional study.

Tada H, Fujiwara N, Tsunematsu T, Tada Y, Arakaki R, Tamaki N, Ishimaru N, Kudo Y.

Clin Exp Dent Res. 2017 Oct 11;3(5):198-203. doi: 10.1002/cre2.88. eCollection 2017 Oct.

9.

Prevention of Pulmonary Edema after Minimally Invasive Cardiac Surgery with Mini-Thoracotomy Using Neutrophil Elastase Inhibitor.

Yamashiro S, Arakaki R, Kise Y, Kuniyoshi Y.

Ann Thorac Cardiovasc Surg. 2018 Feb 20;24(1):32-39. doi: 10.5761/atcs.oa.17-00102. Epub 2017 Nov 8.

10.

Direct reopening of the occluded hepatic veins of Budd-Chiari syndrome: verification of our operative method by the perioperative course of esophageal varices.

Kuniyoshi Y, Inafuku H, Yamashiro S, Kise Y, Nagano T, Arakaki R, Maeda T, Ando M, Higa S.

Gen Thorac Cardiovasc Surg. 2018 Jan;66(1):27-32. doi: 10.1007/s11748-017-0813-x. Epub 2017 Aug 21.

PMID:
28828590
11.

NF-κB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjögren's Syndrome.

Kurosawa M, Arakaki R, Yamada A, Tsunematsu T, Kudo Y, Sprent J, Ishimaru N.

Arthritis Rheumatol. 2017 Nov;69(11):2193-2202. doi: 10.1002/art.40230. Epub 2017 Oct 17.

12.

Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.

Ushio A, Arakaki R, Eguchi H, Hotta F, Yamada A, Kudo Y, Ishimaru N.

Int J Mol Sci. 2017 Jun 6;18(6). pii: E1209. doi: 10.3390/ijms18061209.

13.

Establishment and characterization of a clear cell odontogenic carcinoma cell line with EWSR1-ATF1 fusion gene.

Kujiraoka S, Tsunematsu T, Sato Y, Yoshida M, Ishikawa A, Tohyama R, Tanaka M, Kobayashi Y, Kondo T, Ushio A, Otsuka K, Kurosawa M, Saito M, Yamada A, Arakaki R, Nagai H, Nikai H, Takeuchi K, Nagao T, Miyamoto Y, Ishimaru N, Kudo Y.

Oral Oncol. 2017 Jun;69:46-55. doi: 10.1016/j.oraloncology.2017.04.003. Epub 2017 Apr 10.

PMID:
28559020
14.

Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.

Yamada A, Arakaki R, Saito M, Kudo Y, Ishimaru N.

Front Immunol. 2017 Apr 5;8:403. doi: 10.3389/fimmu.2017.00403. eCollection 2017. Review.

15.

Unique Phenotypes and Functions of Follicular Helper T Cells and Regulatory T Cells in Sjögren's Syndrome.

Saito M, Otsuka K, Ushio A, Yamada A, Arakaki R, Kudo Y, Ishimaru N.

Curr Rheumatol Rev. 2018;14(3):239-245. doi: 10.2174/1573397113666170125122858. Review.

16.

Dysregulation of MAP Kinase Signaling Pathways Including p38MAPK, SAPK/JNK, and ERK1/2 in Cultured Rat Cerebellar Astrocytes Exposed to Diphenylarsinic Acid.

Negishi T, Matsumoto M, Kobayashi Y, Kojima M, Sakaguchi F, Takahata K, Kanehira T, Arakaki R, Aoyama Y, Yoshida H, Yamada R, Sumiyoshi N, Tashiro T, Hirano S, Yoshida K, Yukawa K.

Toxicol Sci. 2017 Apr 1;156(2):509-519. doi: 10.1093/toxsci/kfx012.

PMID:
28087833
17.

The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis.

Izawa T, Arakaki R, Mori H, Tsunematsu T, Kudo Y, Tanaka E, Ishimaru N.

J Immunol. 2016 Dec 15;197(12):4639-4650. Epub 2016 Nov 14.

18.

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.

Arakaki R, Yamasaki T, Kanno T, Shibasaki N, Sakamoto H, Utsunomiya N, Sumiyoshi T, Shibuya S, Tsuruyama T, Nakamura E, Ogawa O, Kamba T.

Cancer Med. 2016 Oct;5(10):2920-2933. doi: 10.1002/cam4.886. Epub 2016 Sep 26.

19.

Human odontogenic epithelial cells derived from epithelial rests of Malassez possess stem cell properties.

Tsunematsu T, Fujiwara N, Yoshida M, Takayama Y, Kujiraoka S, Qi G, Kitagawa M, Kondo T, Yamada A, Arakaki R, Miyauchi M, Ogawa I, Abiko Y, Nikawa H, Murakami S, Takata T, Ishimaru N, Kudo Y.

Lab Invest. 2016 Oct;96(10):1063-75. doi: 10.1038/labinvest.2016.85. Epub 2016 Aug 1.

20.

Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.

Arakaki RF.

Postgrad Med. 2016 May;128(4):409-17. doi: 10.1080/00325481.2016.1167570. Epub 2016 Apr 4. Review.

PMID:
26982554
21.

Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N.

World J Gastroenterol. 2016 Feb 21;22(7):2195-205. doi: 10.3748/wjg.v22.i7.2195. Review.

22.

Molecular Mechanisms of Nickel Allergy.

Saito M, Arakaki R, Yamada A, Tsunematsu T, Kudo Y, Ishimaru N.

Int J Mol Sci. 2016 Feb 2;17(2). pii: E202. doi: 10.3390/ijms17020202. Review.

23.

Recruitment of Asians and Pacific Islanders with Type 2 Diabetes into a Clinical Research Trial of Enhancing Diabetes Self-Management.

Wong LC, Ribeiro M, Vasquez-Brooks M, Estrella D, Wang CY, Arakaki R, Inouye J.

J Cult Divers. 2015 Winter;22(4):142-7.

PMID:
26817172
24.

Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease.

Kondo T, Tsunematsu T, Yamada A, Arakaki R, Saito M, Otsuka K, Kujiraoka S, Ushio A, Kurosawa M, Kudo Y, Ishimaru N.

Lab Invest. 2016 Apr;96(4):468-80. doi: 10.1038/labinvest.2015.166. Epub 2016 Jan 25.

25.

Diphenylarsinic Acid Induced Activation of Cultured Rat Cerebellar Astrocytes: Phosphorylation of Mitogen-Activated Protein Kinases, Upregulation of Transcription Factors, and Release of Brain-Active Cytokines.

Negishi T, Matsumoto M, Kojima M, Asai R, Kanehira T, Sakaguchi F, Takahata K, Arakaki R, Aoyama Y, Yoshida H, Yoshida K, Yukawa K, Tashiro T, Hirano S.

Toxicol Sci. 2016 Mar;150(1):74-83. doi: 10.1093/toxsci/kfv310. Epub 2015 Dec 8.

PMID:
26645585
26.
27.

The Non-Canonical Role of Aurora-A in DNA Replication.

Tsunematsu T, Arakaki R, Yamada A, Ishimaru N, Kudo Y.

Front Oncol. 2015 Aug 25;5:187. doi: 10.3389/fonc.2015.00187. eCollection 2015. Review.

28.

Impaired expansion of regulatory T cells in a neonatal thymectomy-induced autoimmune mouse model.

Yamada A, Ushio A, Arakaki R, Tsunematsu T, Kudo Y, Hayashi Y, Ishimaru N.

Am J Pathol. 2015 Nov;185(11):2886-97. doi: 10.1016/j.ajpath.2015.07.007. Epub 2015 Sep 4.

PMID:
26343329
29.

Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.

Mather KJ, Pan Q, Knowler WC, Funahashi T, Bray GA, Arakaki R, Falkner B, Sharma K, Goldstein BJ; DPP Research Group.

PLoS One. 2015 Aug 27;10(8):e0136853. doi: 10.1371/journal.pone.0136853. eCollection 2015.

30.

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.

Shibasaki N, Yamasaki T, Kanno T, Arakaki R, Sakamoto H, Utsunomiya N, Inoue T, Tsuruyama T, Nakamura E, Ogawa O, Kamba T.

PLoS One. 2015 Jun 26;10(6):e0130980. doi: 10.1371/journal.pone.0130980. eCollection 2015.

31.

Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37:2159-2167.

Wysham C, Blevins T, Arakaki R, Colon G, Garcia P, Atisso C, Kuhstoss D, Lakshmanan M.

Diabetes Care. 2015 Jul;38(7):1393-4. doi: 10.2337/dc15-er07b. No abstract available.

PMID:
26106226
32.

Management of visceral malperfusion complicated with acute type A aortic dissection.

Yamashiro S, Arakaki R, Kise Y, Inafuku H, Kuniyoshi Y.

Interact Cardiovasc Thorac Surg. 2015 Sep;21(3):346-51. doi: 10.1093/icvts/ivv159. Epub 2015 Jun 14.

PMID:
26078384
34.

Aromatase controls Sjögren syndrome-like lesions through monocyte chemotactic protein-1 in target organ and adipose tissue-associated macrophages.

Iwasa A, Arakaki R, Honma N, Ushio A, Yamada A, Kondo T, Kurosawa E, Kujiraoka S, Tsunematsu T, Kudo Y, Tanaka E, Yoshimura N, Harada N, Hayashi Y, Ishimaru N.

Am J Pathol. 2015 Jan;185(1):151-61. doi: 10.1016/j.ajpath.2014.09.006. Epub 2014 Oct 31.

35.
36.

Toxic multinodular goiter in a patient with end-stage renal disease and hemodialysis.

So E, Arakaki R.

Hawaii J Med Public Health. 2014 Jul;73(7):217-20.

37.

Mechanism of activation-induced cell death of T cells and regulation of FasL expression.

Arakaki R, Yamada A, Kudo Y, Hayashi Y, Ishimaru N.

Crit Rev Immunol. 2014;34(4):301-14. Review.

PMID:
24941158
38.

Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1).

Wysham C, Blevins T, Arakaki R, Colon G, Garcia P, Atisso C, Kuhstoss D, Lakshmanan M.

Diabetes Care. 2014 Aug;37(8):2159-67. doi: 10.2337/dc13-2760. Epub 2014 May 30. Erratum in: Diabetes Care. 2014 Oct;37(10):2895. Diabetes Care. 2015 Jul;38(7):1393-4.

PMID:
24879836
39.

Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.

Arakaki R, Eguchi H, Yamada A, Kudo Y, Iwasa A, Enkhmaa T, Hotta F, Mitamura-Aizawa S, Mitamura Y, Hayashi Y, Ishimaru N.

PLoS One. 2014 May 27;9(5):e98390. doi: 10.1371/journal.pone.0098390. eCollection 2014.

40.

Halotolerance, ligninase production and herbicide degradation ability of basidiomycetes strains.

Arakaki RL, Monteiro DA, Boscolo M, Dasilva R, Gomes E.

Braz J Microbiol. 2014 Mar 10;44(4):1207-14. doi: 10.1590/S1517-83822014005000014. eCollection 2013 Dec.

41.

A critical role for thymic stromal lymphopoietin in nickel-induced allergy in mice.

Ashrin MN, Arakaki R, Yamada A, Kondo T, Kurosawa M, Kudo Y, Watanabe M, Ichikawa T, Hayashi Y, Ishimaru N.

J Immunol. 2014 May 1;192(9):4025-31. doi: 10.4049/jimmunol.1300276. Epub 2014 Mar 26.

42.

Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.

Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF; Diabetes Prevention Program Research Group.

Diabet Med. 2014 Sep;31(9):1064-8. doi: 10.1111/dme.12437. Epub 2014 Apr 9.

43.

Emergency operation for aortic dissection with ischemic stroke.

Yamashiro S, Arakaki R, Kise Y, Kuniyoshi Y.

Asian Cardiovasc Thorac Ann. 2014 Feb;22(2):208-11. doi: 10.1177/0218492312469360. Epub 2013 Jul 16.

PMID:
24585797
44.

Giant primary melanoma with no apparent metastases: a report of 2 cases.

Chong TA, Strazzula L, Hoang MP, Arakaki R, Kroshinsky D.

JAMA Dermatol. 2014 May;150(5):574-5. doi: 10.1001/jamadermatol.2013.6892. No abstract available.

PMID:
24477240
45.

Impact of race/ethnicity on efficacy and safety of two starter insulin regimens in patients with type 2 diabetes: a posthoc analysis of the DURABLE trial.

Davidson JA, Wolffenbuttel BH, Arakaki RF, Caballero AE, Jiang HH, Hardin DS.

Ethn Dis. 2013 Autumn;23(4):393-400.

PMID:
24392599
46.

Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial.

Arakaki RF, Blevins TC, Wise JK, Liljenquist DR, Jiang HH, Jacobson JG, Martin SA, Jackson JA.

Diabetes Obes Metab. 2014 Jun;16(6):510-8. doi: 10.1111/dom.12242. Epub 2013 Dec 29.

47.

Associations between Psychosocial and Physiological Factors and Diabetes Health Indicators in Asian and Pacific Islander Adults with Type 2 Diabetes.

Li D, Inouye J, Davis J, Arakaki RF.

Nurs Res Pract. 2013;2013:703520. doi: 10.1155/2013/703520. Epub 2013 Oct 24.

48.

Ethnic differences and β-cell changes.

Arakaki RF.

J Clin Endocrinol Metab. 2013 Sep;98(9):3595-7. doi: 10.1210/jc.2013-2935. No abstract available.

PMID:
24014815
49.

Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.

Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E.

J Clin Endocrinol Metab. 2013 Oct;98(10):3989-98. doi: 10.1210/jc.2013-1452. Epub 2013 Aug 26.

50.

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice.

Kamba T, Yamasaki T, Teramukai S, Shibasaki N, Arakaki R, Sakamoto H, Matsui Y, Okubo K, Yoshimura K, Ogawa O.

Int J Clin Oncol. 2014;19(3):505-15. doi: 10.1007/s10147-013-0581-2. Epub 2013 Jun 28.

PMID:
23813043

Supplemental Content

Loading ...
Support Center